Company Revive Therapeutics Ltd Toronto S.E.
Equities
RVV
CA7615161030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +6.67% | -11.11% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 17/12/19 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 17/12/19 |
William Jackson
BRD | Director/Board Member | - | 31/12/13 |
Andrew Lindzon
BRD | Director/Board Member | 63 | 17/12/19 |
Director/Board Member | 50 | 17/12/19 | |
Joshua Herman
BRD | Director/Board Member | - | 17/12/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 418,564,269 | 412,444,735 ( 98.54 %) | 0 | 98.54 % |
Company contact information
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.comSector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- RVV Stock
- RVV Stock
- Company Revive Therapeutics Ltd